Sai Life Sciences Ltd carries out contract research and manufacturing activities for customers engaged in pharmaceutical and bio technology industriesBusiness Overview: a) SLS is a Hyderabad-based contract research development and manufacturing organisation in the pharmaceutical sector with a significant presence in regulatory markets of US and Europe. b) It offers...
Sai Life Sciences is sending web-link letters to shareholders without registered emails. This provides access to the Integrated Annual Report for FY25-26 ahead of the 27th Annual General Meeting on September 17. Shareholders are advised to register their emails for future communications.
Sai Life Sciences will host its 27th Annual General Meeting via video conference on September 17. Shareholders can access the Integrated Annual Report for FY26 and use the e-voting facility. The cut-off date for voting is September 10, with remote e-voting open from September 14-16.
Sai Life Sciences unveiled robust KPIs, projecting strong growth. Revenue is forecast to hit ₹2,192.49 Cr by Fiscal 2026, with EBITDA reaching ₹652.95 Cr (29.78% margin) and PAT at ₹348.91 Cr. The company also anticipates significant expansion in scientific staff.
Intimation for 26th Annual General Meeting of the Company scheduled to be held on Thursday, 11 September 2025 at 10:30AM (IST)
Sai Life Sciences has scheduled its 26th Annual General Meeting for September 11, 2025, at 10:30 AM IST. The virtual meeting will allow shareholders to review the company's performance for FY 2024-25. Details, including the Annual Report, will be sent out soon. Investors should note this key corporate governance event.
